Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,346 GBX | +0.11% | +2.79% | +16.85% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.85% | 239B | |
+31.69% | 695B | |
+26.51% | 568B | |
-4.80% | 361B | |
+19.44% | 330B | |
+3.54% | 283B | |
+8.66% | 204B | |
-7.85% | 198B | |
+8.82% | 168B | |
+5.09% | 125B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Unit Alexion Discontinues Late-Stage Trial of ALS Drug Candidate Due to Lack of Efficacy